(Q54417851)

English

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

ovarian carcinoma

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Zhi-Yue Rao

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Mu-Yan Cai

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Guo-Fen Yang

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Li-Ru He

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Shi-Juan Mai

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Wen-Feng Hua

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yi-Ji Liao

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hai-Xia Deng

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yang-Chao Chen

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Yi-Xin Zeng

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Hsiang-Fu Kung

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Dan Xie

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

0 references

publication date

28 July 2010

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1576-1583

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20668008%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Epidemiological and molecular aspects of ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Roles of the EZH2 histone methyltransferase in cancer epigenetics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The polycomb group protein EZH2 is involved in progression of prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Lentivirus-mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down-regulation of stathmin.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Oncogenic transformation by SEI-1 is associated with chromosomal instability

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Activated p53 suppresses the histone methyltransferase EZH2 gene.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Overexpression of latent transforming growth factor-beta 1 (TGF-beta 1) binding protein 1 (LTBP-1) in association with TGF-beta 1 in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transition

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Epithelial-mesenchymal transformation of a newly established cell line from ovarian adenosarcoma by transforming growth factor-beta1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Heterogeneous expression and association of ?-catenin, p16 and c-myc in multistage colorectal tumorigenesis and progression detected by tissue microarray

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGQ150

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54417851&oldid=1506790308"